The Food and Drug Administration approved a new combination vaccine for infants, Menhibrix, aimed at preventing the two infections that cause meningitis, meningococcal disease, and Hib disease, all of which can be fatal...
International research that drew on New Zealand’s ground-breaking meningococcal B vaccine campaign is being hailed as a possible breakthrough in the fight against the deadly disease.
A vaccine developed by Serum Institute of India Ltd., led by billionaire Cyrus Poonawalla, was better at protecting people from a strain of meningitis in sub-Saharan Africa than older products